Trichomegaly of Eyelashes after Treatment with Erlotinib in Carcinoma Pancreas

Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Varun, Raina, Shubhra, Chandragouda, D, Singh, Sajjan, Talwar, Vineet, Patnaik, Nivedita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124690/
https://www.ncbi.nlm.nih.gov/pubmed/25114450
http://dx.doi.org/10.4103/0974-7753.136755
Descripción
Sumario:Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair.

Ejemplares similares